An emerging, global biopharma company established to independently pursue the rapidly growing, multi-billion-dollar therapeutic toxin market.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):